Prediction of lactate concentrations after cardiac surgery using machine learning and deep learning approaches.
cardiac surgery
lactate
machine learning
malperfusion
prediction
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
02
2023
accepted:
23
08
2023
medline:
4
10
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
Although conventional prediction models for surgical patients often ignore intraoperative time-series data, deep learning approaches are well-suited to incorporate time-varying and non-linear data with complex interactions. Blood lactate concentration is one important clinical marker that can reflect the adequacy of systemic perfusion during cardiac surgery. During cardiac surgery and cardiopulmonary bypass, minute-level data is available on key parameters that affect perfusion. The goal of this study was to use machine learning and deep learning approaches to predict maximum blood lactate concentrations after cardiac surgery. We hypothesized that models using minute-level intraoperative data as inputs would have the best predictive performance. Adults who underwent cardiac surgery with cardiopulmonary bypass were eligible. The primary outcome was maximum lactate concentration within 24 h postoperatively. We considered three classes of predictive models, using the performance metric of mean absolute error across testing folds: (1) static models using baseline preoperative variables, (2) augmentation of the static models with intraoperative statistics, and (3) a dynamic approach that integrates preoperative variables with intraoperative time series data. 2,187 patients were included. For three models that only used baseline characteristics (linear regression, random forest, artificial neural network) to predict maximum postoperative lactate concentration, the prediction error ranged from a median of 2.52 mmol/L (IQR 2.46, 2.56) to 2.58 mmol/L (IQR 2.54, 2.60). The inclusion of intraoperative summary statistics (including intraoperative lactate concentration) improved model performance, with the prediction error ranging from a median of 2.09 mmol/L (IQR 2.04, 2.14) to 2.12 mmol/L (IQR 2.06, 2.16). For two modelling approaches (recurrent neural network, transformer) that can utilize intraoperative time-series data, the lowest prediction error was obtained with a range of median 1.96 mmol/L (IQR 1.87, 2.05) to 1.97 mmol/L (IQR 1.92, 2.05). Intraoperative lactate concentration was the most important predictive feature based on Shapley additive values. Anemia and weight were also important predictors, but there was heterogeneity in the importance of other features. Postoperative lactate concentrations can be predicted using baseline and intraoperative data with moderate accuracy. These results reflect the value of intraoperative data in the prediction of clinically relevant outcomes to guide perioperative management.
Sections du résumé
Background
UNASSIGNED
Although conventional prediction models for surgical patients often ignore intraoperative time-series data, deep learning approaches are well-suited to incorporate time-varying and non-linear data with complex interactions. Blood lactate concentration is one important clinical marker that can reflect the adequacy of systemic perfusion during cardiac surgery. During cardiac surgery and cardiopulmonary bypass, minute-level data is available on key parameters that affect perfusion. The goal of this study was to use machine learning and deep learning approaches to predict maximum blood lactate concentrations after cardiac surgery. We hypothesized that models using minute-level intraoperative data as inputs would have the best predictive performance.
Methods
UNASSIGNED
Adults who underwent cardiac surgery with cardiopulmonary bypass were eligible. The primary outcome was maximum lactate concentration within 24 h postoperatively. We considered three classes of predictive models, using the performance metric of mean absolute error across testing folds: (1) static models using baseline preoperative variables, (2) augmentation of the static models with intraoperative statistics, and (3) a dynamic approach that integrates preoperative variables with intraoperative time series data.
Results
UNASSIGNED
2,187 patients were included. For three models that only used baseline characteristics (linear regression, random forest, artificial neural network) to predict maximum postoperative lactate concentration, the prediction error ranged from a median of 2.52 mmol/L (IQR 2.46, 2.56) to 2.58 mmol/L (IQR 2.54, 2.60). The inclusion of intraoperative summary statistics (including intraoperative lactate concentration) improved model performance, with the prediction error ranging from a median of 2.09 mmol/L (IQR 2.04, 2.14) to 2.12 mmol/L (IQR 2.06, 2.16). For two modelling approaches (recurrent neural network, transformer) that can utilize intraoperative time-series data, the lowest prediction error was obtained with a range of median 1.96 mmol/L (IQR 1.87, 2.05) to 1.97 mmol/L (IQR 1.92, 2.05). Intraoperative lactate concentration was the most important predictive feature based on Shapley additive values. Anemia and weight were also important predictors, but there was heterogeneity in the importance of other features.
Conclusion
UNASSIGNED
Postoperative lactate concentrations can be predicted using baseline and intraoperative data with moderate accuracy. These results reflect the value of intraoperative data in the prediction of clinically relevant outcomes to guide perioperative management.
Identifiants
pubmed: 37790131
doi: 10.3389/fmed.2023.1165912
pmc: PMC10543087
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1165912Informations de copyright
Copyright © 2023 Kobayashi, Peng, Yu, Bush, Jung, Murphy, Goeddel, Whitman, Venkataraman and Brown.
Déclaration de conflit d'intérêts
CB has received grant support from Medtronic in unrelated areas and discloses this relationship for all disclosures, regardless of whether or not it could be construed as a conflict. GW is the director of the executive study board for the Cryptics study, sponsored by Avania, and is the co-founder and co-owner of a start-up company to build a device for easier central line insertion (GWBN, LLC). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1441-53
pubmed: 26321121
JAMA Netw Open. 2022 Oct 3;5(10):e2237970
pubmed: 36287565
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Ann Card Anaesth. 2016 Oct-Dec;19(4):668-675
pubmed: 27716698
Mayo Clin Proc. 2013 Oct;88(10):1127-40
pubmed: 24079682
Anesth Analg. 2022 Jan 1;134(1):102-113
pubmed: 34908548
J Cardiothorac Vasc Anesth. 2017 Feb;31(1):45-53
pubmed: 27542901
Semin Thorac Cardiovasc Surg. 2015 Summer;27(2):144-51
pubmed: 26686440
J Extra Corpor Technol. 2017 Mar;49(1):7-15
pubmed: 28298660
Anesthesiology. 2021 Apr 1;134(4):637-644
pubmed: 33332524
JAMA Netw Open. 2021 Mar 1;4(3):e212240
pubmed: 33783520
J Thorac Cardiovasc Surg. 2023 Apr;165(4):1449-1459.e15
pubmed: 34607725
Front Med (Lausanne). 2021 Dec 02;8:763931
pubmed: 34926506
J Surg Res. 2021 Aug;264:68-75
pubmed: 33784585
Ann Thorac Surg. 2017 Jan;103(1):66-73
pubmed: 27546600